Monoclonal antibody · Antagonist of T-cell immunoglobulin and mucin domain-containing protein 3 (HAVCR2)
Phase 1/2Most advanced trial
1Registered trials
What is S095018?
S095018 is a recombinant, fully human monoclonal antibody that binds TIM-3, an inhibitory immune checkpoint receptor expressed on certain T cells, including tumor infiltrating lymphocytes. By blocking TIM-3, it abrogates T-cell inhibition and enhances T-cell-mediated tumor cell killing. It is being studied in non-small cell lung cancer.
Summary written with AI from the sources listed at the end of this page.
At a glance
Also known as
S-95018
Drug type
Monoclonal antibody
Targets
T-cell immunoglobulin and mucin domain-containing protein 3 (HAVCR2)
Mechanism
Antagonist of T-cell immunoglobulin and mucin domain-containing protein 3 (HAVCR2)
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.